S&P 5007,785.76▼0.2% Nasdaq26,729.16▼0.3% Dow53,732.41▼0.2% Russell 2K3,068.42▲0.5% 10-Yr4.70%+6bp VIX14.25−0.38 WTI$82.40▲1.4% Gold$4,432.00▲1.6% EUR/USD1.157▲0.4% BTC$62,958▼0.7% Nikkei68,309▲1.2%
At close · Fri, Aug 14, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›Appeals court blocks overseas imports of Gilead drugs…

Appeals court blocks overseas imports of Gilead drugs for AFP programs

Reported · Written up by our desk · M&A & Deals

CNBC Markets reports that a U.S. appeals court ruled in favor of Gilead Sciences, blocking companies tied to alternative funding programs from importing Gilead medications from overseas.

The decision is framed as a setback for AFP health programs that rely on those cross-border imports of the drugs.

← Newer storyNZD/USD edges higher toward 0.5900 as the US dollar weakens

More like this

US MarketsJefferies upgrades Five Below with a $350 price target
US MarketsCuraleaf Chief Defends $4-a-Share Aurora Bid as Talks Turn Hostile
US MarketsQuantinuum to place Helios quantum system inside Oracle Cloud data centers
US MarketsDatabricks closes $5 billion round at $190 billion valuation
US MarketsAcertus acquires Fisher Shipping to expand its auto logistics platform

Sources

CNBC MarketsCourt rules companies can't import Gilead medications from overseas in blow to AFP health programs

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.